Trial Profile
A Randomized, Double-blind, Placebo-controlled, Doseescalation Trial to Evaluate the Safety and Tolerability of a Single IV Administration of Dasiglucagon and the Bioavailability of Dasiglucagon Following SC Compared to IV Administration in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Mar 2021
Price :
$35
*
At a glance
- Drugs Dasiglucagon (Primary) ; Dasiglucagon (Primary)
- Indications Hypoglycaemia
- Focus Adverse reactions
- Sponsors Zealand Pharma
- 25 Jun 2019 Status changed from recruiting to completed.
- 05 Apr 2019 Planned End Date changed from 20 Feb 2019 to 28 Jun 2019.
- 05 Apr 2019 Planned primary completion date changed from 20 Jan 2019 to 28 Jun 2019.